ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
CP005971 |
|
71119-22-7 |
Sodium 3-morpholinopropanesulfonate - 98% |
0 | C7H14NNaO4S | |
CP000508 |
|
3618-43-7 |
tetrasodium N,N'-[3H-2,1-benzoxathiol-3-ylidenebis[(6-hydroxy-5-methylphen-3,1-ylene)methylene]]bis[N-(carboxylatomethyl)aminoacetate] S,S-dioxide - 99% |
0 | C31H31N2O13S-4.4[NA ] | |
CP008459 |
|
6001-64-5 |
Chlorobutanol - 99% |
0 | C4H7Cl3O.1/2H2O | |
CP002887 |
|
52-68-6 |
Chlorophos - 90% |
0 | C4H8CL3O4P | |
CP004868 |
|
91-57-6 |
2-Methylnaphthalene - |
0 | C11H10 | |
CP006659 |
|
— |
N/A - |
0 | — | |
CP007474 |
|
1374639-75-4 |
LEE011 Succinate - |
0 | C27H36N8O5 | |
CP000740 |
|
864731-61-3 |
Fluralaner - ≥95% |
0 | C22H17Cl2F6N3O3 | |
CP005021 |
|
37342-97-5 |
Bis(cyclopentadienyl)zirconium chloride hydride - ≥95% |
0 | C10H11ClZr | |
CP008462 |
|
13061-96-6 |
Methylboronic acid - |
0 | CH5BO2 | |
CP005303 |
|
1374853-91-4 |
Lambrolizumab - 98% |
0 | — | |
CP002074 |
|
14984-34-0 |
D-Glucuronic acid sodium salt - |
0 | C6H9NAO7 | |
CP008431 |
|
1397836-41-7 |
(Z)-Ethyl-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl) biphenyl-4-yl) Methyl)-3H-benzo[d] iMidazole-4-carboxylate - |
0 | C26H26N4O4 | |
CP002362 |
|
68399-80-4 |
3-[bis(2-hydroxyethyl)amino]-2-hydroxypropanesulphonic acid - 99% |
0 | C7H17NO6S | |
CP002997 |
|
62932-94-9 |
2-BROMO-1-[4-HYDROXY-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE - 98% |
0 | C9H9BRO3 | |
CP004112 |
|
375823-41-9 |
Tocilizumab - 98% |
0 | — | |
CP001450 |
|
1397836-41-7 |
(Z)-Ethyl-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl) biphenyl-4-yl) Methyl)-3H-benzo[d] iMidazole-4-carboxylate - |
0 | C26H26N4O4 | |
CP000523 |
|
317-20-4 |
7-Fluoroisatin - 98% |
0 | C8H4FNO2 | |
CP002678 |
|
110638-68-1 |
Calcium Lactobionate Hydrate - 99% |
0 | C24H42CaO24 | |
CP005912 |
|
6092-54-2 |
Hexyl carbonochloridate - |
0 | C7H13CLO2 | |